Teva to Present at the 41st Annual J.P. Morgan Healthcare Conference
To access a live webcast of the presentation, visit Teva’s Investor Relations website at http://ir.tevapharm.com/.
An archived version of the webcast will be available within 24 hours after the end of the live discussion and will be accessible for up to 30 days.
About Teva
Cautionary Note Regarding Forward-Looking Statements
This document and the conference call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management’s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. Important factors that could cause or contribute to such differences include risks relating to: our ability to successfully compete in the marketplace; our substantial indebtedness; our business and operations in general including: uncertainty regarding the COVID-19 pandemic and the governmental and societal responses thereto; compliance, regulatory and litigation matters; other financial and economic risks; and other factors discussed in our Quarterly Rerport on Form 10-Q for the third quarter of 2022 and in our Annual Report on Form 10-K for the year ended
View source version on businesswire.com: https://www.businesswire.com/news/home/20230103005134/en/
IR Contacts
(267) 468-4475
+972 (3) 914 8262
PR Contacts
(973) 832-2810
+972 (3) 906 2645
Source: